The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma
- PMID: 27471686
- PMCID: PMC4928366
- DOI: 10.2147/ITT.S31971
The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma
Abstract
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder mediated by autoantibodies to voltage-gated calcium channels. The disorder is diagnosed clinically on the basis of a triad of symptoms (proximal muscle weakness, hyporeflexia, and autonomic disturbance), supported by electrophysiological findings and the presence of autoantibodies. Between 40% and 62% of patients diagnosed with LEMS are found to have small-cell lung cancer (SCLC), almost all of whom develop neurological symptoms before their cancer is diagnosed. Prompt identification of LEMS and appropriate screening for SCLC is key to improving the outcome of both conditions. Here we review the pathophysiology and clinical management of LEMS, focusing particularly on the relationship with SCLC.
Keywords: Lambert–Eaton; autoimmune; small-cell lung cancer.
References
-
- O’Neill JH, Murray NMF, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome – a review of 50 cases. Brain. 1988;111(Pt 3):577–596. - PubMed
-
- Anderson HJ, Churchill-Davidson HC, Richardson AT. Bronchial neoplasm with myasthenia; prolonged apnoea after administration of succinylcholine. Lancet. 1953;265(6799):1291–1293. - PubMed
-
- Heathfield KW, Williams JR. Peripheral neuropathy and myopathy associated with bronchogenic carcinoma. Brain. 1954;77(1):122–137. - PubMed
-
- Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physiol. 1956;187(3):612–613.
-
- Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. JAMA. 1957;163(13):1117–1124. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources